MX2009013646A - Metodos de diagnostico y tratamiento del cancer. - Google Patents
Metodos de diagnostico y tratamiento del cancer.Info
- Publication number
- MX2009013646A MX2009013646A MX2009013646A MX2009013646A MX2009013646A MX 2009013646 A MX2009013646 A MX 2009013646A MX 2009013646 A MX2009013646 A MX 2009013646A MX 2009013646 A MX2009013646 A MX 2009013646A MX 2009013646 A MX2009013646 A MX 2009013646A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- diagnosing
- treating cancer
- levels
- rrm1
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Abstract
La invención se refiere a métodos para determinar una terapia de cáncer apropiada para un sujeto con base en niveles de expresión intratumorales de expresión de gen de ribonucleótjdo reductasa Ml (RRM1) y timidilato sintasa (TS), así como métodos para predecir el resultado clínico (pronóstico) con base en niveles citoplásmicos de proteína TS. También se proporcionan composiciones y kits útiles para los métodos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94415707P | 2007-06-15 | 2007-06-15 | |
US3955508P | 2008-03-26 | 2008-03-26 | |
PCT/US2008/066918 WO2008157353A1 (en) | 2007-06-15 | 2008-06-13 | Methods of diagnosing and treating cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009013646A true MX2009013646A (es) | 2010-03-30 |
Family
ID=40156627
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009013646A MX2009013646A (es) | 2007-06-15 | 2008-06-13 | Metodos de diagnostico y tratamiento del cancer. |
Country Status (12)
Country | Link |
---|---|
US (1) | US20090017012A1 (es) |
EP (1) | EP2171086B1 (es) |
JP (1) | JP5479332B2 (es) |
KR (1) | KR20100044780A (es) |
CN (1) | CN101815793A (es) |
AU (1) | AU2008266048A1 (es) |
BR (1) | BRPI0813364A2 (es) |
CA (1) | CA2690865A1 (es) |
ES (1) | ES2401475T3 (es) |
MX (1) | MX2009013646A (es) |
RU (1) | RU2010101093A (es) |
WO (1) | WO2008157353A1 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2460886B1 (en) * | 2005-05-04 | 2014-01-01 | University of South Florida | Predicting treatment response in cancer subjects |
WO2007137187A2 (en) | 2006-05-18 | 2007-11-29 | Molecular Profiling Institute, Inc. | System and method for determining individualized medical intervention for a disease state |
US8768629B2 (en) * | 2009-02-11 | 2014-07-01 | Caris Mpi, Inc. | Molecular profiling of tumors |
GB2463401B (en) | 2008-11-12 | 2014-01-29 | Caris Life Sciences Luxembourg Holdings S A R L | Characterizing prostate disorders by analysis of microvesicles |
JP5024736B2 (ja) * | 2009-10-15 | 2012-09-12 | 住友電気工業株式会社 | 発電システム |
CA2791905A1 (en) | 2010-03-01 | 2011-09-09 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Biomarkers for theranostics |
CN107158389A (zh) | 2010-03-29 | 2017-09-15 | 阿布拉科斯生物科学有限公司 | 增强药物递送和治疗剂有效性的方法 |
NZ602385A (en) | 2010-03-29 | 2014-08-29 | Abraxis Bioscience Llc | Methods of treating cancer |
AU2011237669B2 (en) | 2010-04-06 | 2016-09-08 | Caris Life Sciences Switzerland Holdings Gmbh | Circulating biomarkers for disease |
KR101602532B1 (ko) * | 2013-08-29 | 2016-03-11 | 경북대학교 산학협력단 | 위암의 재발 가능성 예측을 위한 정보제공 방법 |
EP3396573A4 (en) * | 2015-10-26 | 2019-08-28 | Cipherome | METHOD AND SYSTEM FOR SELECTING A CUSTOMIZED MEDICINE USING GENOMIC NUCLEOTIDE SEQUENCE VARIATION INFORMATION AND CANCER PATIENT SURVIVAL INFORMATION |
JP2023534208A (ja) * | 2020-07-10 | 2023-08-08 | プロゲニクス ファーマシューティカルズ,インコーポレーテッド | 前立腺がん処置判断を行う方法 |
CN113957145B (zh) * | 2021-10-19 | 2023-09-26 | 中国医学科学院肿瘤医院 | m6A相关lncRNA在预测小细胞肺癌预后和化疗反应的应用 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5705336A (en) * | 1995-03-07 | 1998-01-06 | The United States Of America As Represented By The Department Of Health And Human Services | Assay for sensitivity of tumors to DNA-platinating chemotherapy |
US20020090642A1 (en) * | 1995-12-11 | 2002-07-11 | Patrick G. Johnston | Methods for determining the prognosis of breast cancer using antibodies specific for thymidylate synthase |
WO1998033518A1 (en) * | 1997-02-04 | 1998-08-06 | Sloan-Kettering Institute For Cancer Research | Mutants of thymidylate synthase and uses thereof |
US6087489A (en) * | 1998-06-02 | 2000-07-11 | Isis Pharmaceuticals Inc. | Antisense oligonucleotide modulation of human thymidylate synthase expression |
ATE528392T1 (de) * | 1999-06-28 | 2011-10-15 | Yusuke Nakamura | Neues protein und dessen dns |
US6248535B1 (en) * | 1999-12-20 | 2001-06-19 | University Of Southern California | Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens |
US6518416B1 (en) * | 2000-12-01 | 2003-02-11 | Response Genetics, Inc. | Method of determining a chemotherapeutic regimen based on ERCC1 expression |
US7049059B2 (en) * | 2000-12-01 | 2006-05-23 | Response Genetics, Inc. | Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression |
US6582919B2 (en) * | 2001-06-11 | 2003-06-24 | Response Genetics, Inc. | Method of determining epidermal growth factor receptor and HER2-neu gene expression and correlation of levels thereof with survival rates |
US6602670B2 (en) * | 2000-12-01 | 2003-08-05 | Response Genetics, Inc. | Method of determining a chemotherapeutic regimen based on ERCC1 expression |
US6956111B2 (en) * | 2001-03-02 | 2005-10-18 | Response Genetics, Inc. | Method of determining dihydropyrimidine dehydrogenase gene expression |
US6686155B2 (en) * | 2001-06-14 | 2004-02-03 | Response Genetics, Inc. | Method of determining a chemotherapeutic regimen based on glutathione-S-transferase pi expression |
WO2004031408A1 (en) * | 2002-09-30 | 2004-04-15 | F.Hoffmann-La Roche Ag | Oligonucleotides for genotyping thymidylate synthase gene |
WO2005042760A2 (en) * | 2003-09-29 | 2005-05-12 | Pathwork Informatics, Inc. | Systems and methods for detecting biological features |
EP2460886B1 (en) * | 2005-05-04 | 2014-01-01 | University of South Florida | Predicting treatment response in cancer subjects |
-
2008
- 2008-06-13 EP EP08771019A patent/EP2171086B1/en not_active Not-in-force
- 2008-06-13 US US12/139,134 patent/US20090017012A1/en not_active Abandoned
- 2008-06-13 WO PCT/US2008/066918 patent/WO2008157353A1/en active Application Filing
- 2008-06-13 JP JP2010512384A patent/JP5479332B2/ja not_active Expired - Fee Related
- 2008-06-13 BR BRPI0813364-6A2A patent/BRPI0813364A2/pt not_active IP Right Cessation
- 2008-06-13 RU RU2010101093/10A patent/RU2010101093A/ru not_active Application Discontinuation
- 2008-06-13 CA CA2690865A patent/CA2690865A1/en not_active Abandoned
- 2008-06-13 AU AU2008266048A patent/AU2008266048A1/en not_active Abandoned
- 2008-06-13 MX MX2009013646A patent/MX2009013646A/es not_active Application Discontinuation
- 2008-06-13 KR KR1020107000955A patent/KR20100044780A/ko not_active Application Discontinuation
- 2008-06-13 ES ES08771019T patent/ES2401475T3/es active Active
- 2008-06-13 CN CN200880102571A patent/CN101815793A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
ES2401475T3 (es) | 2013-04-19 |
RU2010101093A (ru) | 2011-07-20 |
JP2010530746A (ja) | 2010-09-16 |
US20090017012A1 (en) | 2009-01-15 |
CN101815793A (zh) | 2010-08-25 |
KR20100044780A (ko) | 2010-04-30 |
JP5479332B2 (ja) | 2014-04-23 |
BRPI0813364A2 (pt) | 2014-12-30 |
EP2171086B1 (en) | 2012-12-19 |
AU2008266048A1 (en) | 2008-12-24 |
EP2171086A1 (en) | 2010-04-07 |
CA2690865A1 (en) | 2008-12-24 |
WO2008157353A1 (en) | 2008-12-24 |
EP2171086A4 (en) | 2010-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009013646A (es) | Metodos de diagnostico y tratamiento del cancer. | |
WO2007034221A3 (en) | Non small cell lung cancer therapy prognosis and target | |
TWI317811B (es) | ||
WO2008008500A3 (en) | Methods for making cancer prognoses based on the subcellular localization of biomarkers | |
WO2006138275A3 (en) | Compositions and methods for treating and diagnosing cancer | |
WO2010004591A3 (en) | Genetic variants for breast cancer risk assessment | |
WO2007053648A3 (en) | Compositions and methods for treating and diagnosing cancer | |
WO2010018601A3 (en) | Genetic variants predictive of cancer risk | |
WO2008061213A3 (en) | Genetic variations associated with tumors | |
WO2013009655A3 (en) | Uses of labeled hsp90 inhibitors | |
WO2008146309A3 (en) | Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment | |
WO2008036691A3 (en) | Biomarkers for prostate cancer and methods using the same | |
WO2008061104A3 (en) | Methods and kits for detecting prostate cancer biomarkers | |
NZ591613A (en) | Polymorphic marker rs965513 for risk assessment of thyroid cancer | |
WO2003097803A3 (en) | Cancer-linked gene as target for chemotherapy | |
WO2003101400A3 (en) | Cancer-linked gene as target for chemotherapy | |
WO2007123772A3 (en) | Genes involved in estrogen metabolism | |
WO2009037572A3 (en) | Biomarker combinations for colorectal cancer | |
WO2011015944A3 (en) | Use of free dna as an early predictor of severity in acute pancreatitis | |
WO2008070301A3 (en) | Predicting lung cancer survival using gene expression | |
WO2008117314A3 (en) | Genetic variants on chr2 and chr16 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment | |
WO2004097052A3 (en) | Methods for prognosis and treatment of solid tumors | |
WO2007058968A3 (en) | Gene expression profiles and methods of use | |
MX2013000502A (es) | Metodos y kits para el diagnostico de cancer de prostata. | |
MX2007013727A (es) | Caracterizacion de cancer de prostata. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |